These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36851510)

  • 21. Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infection.
    Simayi A; Li C; Chen C; Wang Y; Dong C; Tian H; Kong X; Zhou L; Peng J; Zhang S; Zhu F; Hu J; Xu K; Jin H; Fan H; Bao C; Zhu L
    Front Immunol; 2023; 14():1083523. PubMed ID: 36761738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S.
    Ahmed MIM; Plank M; Castelletti N; Diepers P; Eser TM; Rubio-Acero R; Noreña I; Reinkemeyer C; Zapf D; Hoelscher M; Janke C; Wieser A; Geldmacher C; On Behalf Of The KoCo/Orchestra Study Group
    Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis.
    van Kempen ZLE; Stalman EW; Steenhuis M; Kummer LYL; van Dam KPJ; Wilbrink MF; Ten Brinke A; van Ham SM; Kuijpers T; Rispens T; Eftimov F; Wieske L; Killestein J;
    J Neurol Neurosurg Psychiatry; 2023 Apr; 94(4):280-283. PubMed ID: 36564175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.
    Boekel L; Stalman EW; Wieske L; Hooijberg F; van Dam KPJ; Besten YR; Kummer LYL; Steenhuis M; van Kempen ZLE; Killestein J; Volkers AG; Tas SW; van der Kooi AJ; Raaphorst J; Löwenberg M; Takkenberg RB; D'Haens GRAM; Spuls PI; Bekkenk MW; Musters AH; Post NF; Bosma AL; Hilhorst ML; Vegting Y; Bemelman FJ; Voskuyl AE; Broens B; Parra Sanchez A; van Els CACM; de Wit J; Rutgers A; de Leeuw K; Horváth B; Verschuuren JJGM; Ruiter AM; van Ouwerkerk L; van der Woude D; Allaart CF; Teng YKO; van Paassen P; Busch MH; Jallah PBP; Brusse E; van Doorn PA; Baars AE; Hijnen DJ; Schreurs CRG; van der Pol WL; Goedee HS; Vogelzang EH; Leeuw M; Atiqi S; van Vollenhoven R; Gerritsen M; van der Horst-Bruinsma IE; Lems WF; Nurmohamed MT; Boers M; Keijzer S; Keijser J; van de Sandt C; Boogaard A; Cristianawati O; Ten Brinke A; Verstegen NJM; Zwinderman KAH; van Ham SM; Rispens T; Kuijpers TW; Wolbink G; Eftimov F;
    Lancet Rheumatol; 2022 Jun; 4(6):e417-e429. PubMed ID: 35527808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave.
    Al Jurdi A; Morena L; Cote M; Bethea E; Azzi J; Riella LV
    Am J Transplant; 2022 Dec; 22(12):3130-3136. PubMed ID: 35727916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant Recipients.
    Davidov Y; Indenbaum V; Atari N; Kliker L; Tsaraf K; Asraf K; Cohen-Ezra O; Likhter M; Mor O; Doolman R; Weiss-Ottolenghi Y; Hod T; Afek A; Kreiss Y; Lustig Y; Regev-Yochay G; Mandelboim M; Ben-Ari Z
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.
    Sormani MP; Schiavetti I; Inglese M; Carmisciano L; Laroni A; Lapucci C; Visconti V; Serrati C; Gandoglia I; Tassinari T; Perego G; Brichetto G; Gazzola P; Mannironi A; Stromillo ML; Cordioli C; Landi D; Clerico M; Signoriello E; Cocco E; Frau J; Ferrò MT; Di Sapio A; Pasquali L; Ulivelli M; Marinelli F; Pizzorno M; Callari G; Iodice R; Liberatore G; Caleri F; Repice AM; Cordera S; Battaglia MA; Salvetti M; Franciotta D; Uccelli A;
    EBioMedicine; 2022 Jun; 80():104042. PubMed ID: 35526306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
    Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
    BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral and cellular immune responses to Pfizer-BioNTech BNT162b2 SARS-CoV-2 vaccine in adolescents with liver transplantation: Single center experience.
    Sánchez-Zapardiel E; Alós M; Nozal P; González-Muñoz M; Frauca-Remacha E; Gavilán LB; Quiles MJ; Hierro L; López-Granados E
    Front Immunol; 2022; 13():1049188. PubMed ID: 36505469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants.
    Wang XJ; Yao L; Zhang HY; Zhu KL; Zhao J; Zhan BD; Li YK; He XJ; Huang C; Wang ZY; Jiang MD; Yang P; Yang Y; Wang GL; Wang SQ; Dai EH; Gao HX; Ma MJ
    Genome Med; 2022 Dec; 14(1):146. PubMed ID: 36581867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients.
    Zhang L; Yang J; Lai C; Wan L; Xiong S; Kong W; Liu Z; Yu P; Chen M; Mai W; Khan SA; Deng M; Chen L; Lei Y; Zhou Q; Yu N; Li P; Chen Z; Ji T
    Front Immunol; 2022; 13():1042784. PubMed ID: 36700230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Omicron BA.1 infection on BA.4/5 immunity in transplant recipients.
    Ferreira VH; Hu Q; Kurtesi A; Solera JT; Ierullo M; Gingras AC; Kumar D; Humar A
    Am J Transplant; 2023 Feb; 23(2):278-283. PubMed ID: 36744606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease Course, Management and Outcomes in Kidney Transplant Recipients with SARS-CoV-2 Infection during the Omicron-Variant Wave: A Single-Center Experience.
    Korogiannou M; Vallianou K; Xagas E; Rokka E; Soukouli I; Boletis IN; Marinaki S
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination with BNT162b2 and ChAdOx1 nCoV-19 Induces Cross-Reactive Anti-RBD IgG against SARS-CoV-2 Variants including Omicron.
    Gerges D; Kapps S; Hernández-Carralero E; Freire R; Aiad M; Schmidt S; Winnicki W; Reiter T; Pajenda S; Schmidt A; Sunder-Plassmann G; Wagner L
    Viruses; 2022 May; 14(6):. PubMed ID: 35746653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients.
    Gallais F; Renaud-Picard B; Solis M; Laugel E; Soulier E; Caillard S; Kessler R; Fafi-Kremer S
    J Heart Lung Transplant; 2022 Oct; 41(10):1429-1439. PubMed ID: 35953352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Vaccination and Early Monoclonal Antibody Therapy on Coronavirus Disease 2019 Outcomes in Organ Transplant Recipients During the Omicron Wave.
    Solera JT; Árbol BG; Alshahrani A; Bahinskaya I; Marks N; Humar A; Kumar D
    Clin Infect Dis; 2022 Dec; 75(12):2193-2200. PubMed ID: 35445690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine.
    Grupper A; Katchman E; Ben-Yehoyada M; Rabinowich L; Schwartz D; Schwartz IF; Shashar M; Halperin T; Turner D; Goykhman Y; Shibolet O; Levy S; Houri I; Baruch R; Katchman H
    Clin Transplant; 2021 Dec; 35(12):e14478. PubMed ID: 34506644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients.
    Benning L; Morath C; Bartenschlager M; Kim H; Reineke M; Beimler J; Buylaert M; Nusshag C; Kälble F; Reichel P; Töllner M; Schaier M; Klein K; Benes V; Rausch T; Rieger S; Stich M; Tönshoff B; Weidner N; Schnitzler P; Zeier M; Süsal C; Hien Tran T; Bartenschlager R; Speer C
    Am J Transplant; 2022 Jul; 22(7):1873-1883. PubMed ID: 35384272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
    PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controls.
    Balsby D; Nilsson AC; Petersen I; Lindvig SO; Davidsen JR; Abazi R; Poulsen MK; Holden IK; Justesen US; Bistrup C; Johansen IS
    Front Immunol; 2022; 13():1039245. PubMed ID: 36569919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.